Carrie Ambler
Carrie Ambler is a professor in the Biosciences Department at Durham University and also Chief Scientific Officer of a spinout company, LightOx. Her work directly impacted the synthesis and biological testing of new fluorescent chemicals for use as life sciences tools. These are now commercially available worldwide through Merck and are being developed to produce light-activated therapeutics for oral cancer treatments.
Register for FREE to unlock this article
We are committed to providing unparalleled insights and the latest news in the photonics industry. By joining our community for free, you gain exclusive access to:
- Breaking News & Industry Updates: Stay ahead with real-time updates on technological advancements and market trends.
- Expert Analysis & In-Depth Features: Dive deep into comprehensive articles that provide expert commentary and explore the implications of new developments.
- Insights from Photonics Leaders: Gain unique perspectives through interviews and profiles of leading researchers and innovators, such as The Photonics100.
- Industry Webinars and Round Tables: Be the first to hear about upcoming webinars and in-person events addressing the challenges faced by the photonics community and the best-practice ways to solve them.
- Access to Premium Content: Unlock technical articles and special reports into the science and engineering of photonics.
- Exclusive Technology Reviews & Product Announcements: Access our year-round updates on cutting-edge products and innovations transforming the industry.
Don’t miss out on the opportunity to enhance your knowledge and stay informed. Join our thriving community today and become a part of the leading source for photonics news and insights.
Sign up now – it’s fast, easy, and FREE!
Already registered? Log in here to keep reading
You can see our full privacy policy here.
